We continue to focus on delivering meaningful impact for patients and long-term value for our shareholders.” Altimmune ...

KØBENHAVN, DK / ACCESS Newswire / January 21, 2026 / FluoGuide A/S ("FluoGuide" or the "Company")(STO:FLUO), a biotech company maximizing surgical outcomes in oncology by lighting up cancer, today ...

Discusses Zydus Collaboration, Global Manufacturing Expansion, and Patient Access Initiatives January 28, 2026 4:00 PM ...

KØBENHAVN, DK / ACCESS Newswire / January 21, 2026 / FluoGuide A/S ("FluoGuide" or the "Company")(STO:FLUO), a biotech company maximizing surgical outcomes in oncology by lighting up cancer, today ann ...

Diabetic neuropathy is a common, progressive complication of diabetes characterized by nerve damage that leads to chronic ...

MELBOURNE, Australia and INDIANAPOLIS, Jan. 16, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, ...

Pricing of $12.5 Million Registered Direct Offering & Concurrent Private Placement Offerings priced at-the-market under Nasdaq rules ...

Breakthrough Therapy Designation granted to NXC-201 based on positive NEXICART-2 Phase 2 interim clinical results, presented at the American ...

Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide to improve the lives of ...

Slope is the only end-to-end, vendor-agnostic platform for managing biospecimens and clinical inventory across the entire clinical research ecosystem. Trusted by 2,200+ sites in 23+ countries, Slope ...

The Supreme Court on Thursday refused to exercise its writ jurisdiction to prescribe uniform, binding guidelines for crowd management at political rallies and large public congregations across the ...

Breakthrough Therapy Designation granted to NXC-201 based on positive NEXICART-2 Phase 2 interim clinical results, presented at the American Society of Hematology (ASH) 2025 annual meeting - - Final ...